Genetic Analysis operates in medical technology. The company conducts research and development in the field of diagnostics, with the main focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.

Quotes for Genetic Analysis AS

Right Now

+/-
0.025
%
5,38%
Latest
0.49
High
0.49
Low
0.43
Volume
22 013
Turnover (NOK)
10 185
Market Value (MNOK)
23,9
Time (Latest trade)

Board

CEO

  • Ronny Hermansen

Chairperson of the Board

  • Jethro Holter

Board

  • Camilla Huse Bondesson
  • Marie Buchmann
  • Richard Kurtz
  • Rune Sørum
  • Thorvald Steen

Largest Owners

Name Capital % Votes % Date
Bio-Rad Luxembourg S.À.R.L. 22,49 22,49 2024-09-30
Avanza Bank AB 11,12 11,12 2024-09-30
Muen Invest AS 6,55 6,55 2024-09-30
Nordnet Bank AB 4,86 4,86 2024-09-30
Lucellum AS 4,86 4,86 2024-09-30
Ochrino AS 4,16 4,16 2024-09-30
S. Munkhaugen AS 3,54 3,54 2024-09-30
Molver AS 2,93 2,93 2024-09-30
Biohit Oyj 2,88 2,88 2024-09-30
Leif Jørgen Moger 2,67 2,67 2024-09-30

Upcoming reports

  • 2025-02-26 Bokslutskommuniké 2024